Chemoinformaics analysis of BENZYLADENINE-3-O-BETA-D-GLUCOSIDE
| Molecular Weight | 387.396 | nRot | 5 |
| Heavy Atom Molecular Weight | 366.228 | nRig | 23 |
| Exact Molecular Weight | 387.154 | nRing | 4 |
| Solubility: LogS | -2.76 | nHRing | 3 |
| Solubility: LogP | -0.177 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 3 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 49 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 28 | No. of Aromatic Carbocycles | 1 |
| nHetero | 10 | No. of Aromatic Hetero Cycles | 2 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 21 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 18 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 5 | No. of Arom Atom | 15 |
| No. of Oxygen atom | 5 | No. of Arom Bond | 16 |
| nHA | 10 | APOL | 53.5727 |
| nHD | 5 | BPOL | 28.5033 |
| QED | 0.379 |
| Synth | 4.128 |
| Natural Product Likeliness | 0.867 |
| NR-PPAR-gamma | 0.04 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0 |
| Pgp-sub | 0.747 |
| HIA | 0.988 |
| CACO-2 | -5.548 |
| MDCK | 0.00000524 |
| BBB | 0.743 |
| PPB | 0.262332 |
| VDSS | 2.621 |
| FU | 0.639908 |
| CYP1A2-inh | 0.028 |
| CYP1A2-sub | 0.131 |
| CYP2c19-inh | 0.017 |
| CYP2c19-sub | 0.064 |
| CYP2c9-inh | 0.001 |
| CYP2c9-sub | 0.31 |
| CYP2d6-inh | 0.066 |
| CYP2d6-sub | 0.046 |
| CYP3a4-inh | 0.06 |
| CYP3a4-sub | 0.107 |
| CL | 8.96 |
| T12 | 0.689 |
| hERG | 0.049 |
| Ames | 0.082 |
| ROA | 0.456 |
| SkinSen | 0.084 |
| Carcinogencity | 0.039 |
| EI | 0.007 |
| Respiratory | 0.858 |
| NR-Aromatase | 0.926 |
| Antiviral | Yes |
| Prediction | 0.89733 |